Structural and Functional Outcomes in Chronic Central Serous Chorioretinopathy Treated with Photodynamic Therapy

다국어 초록 (Multilingual Abstract)

Purpose: To study the retinal pigment epithelium (RPE) and retinal alterations in chronic central serous chorioretinopathy treated with photodynamic therapy, and its correlation with functional parameters such as best-corrected visual acuity (BCVA) and contrast sensitivity (CS).
Methods: Retrospective, noncomparative, consecutive evaluation by optical coherence tomography and its correlation with BCVA and CS in 31 eyes of 26 patients.
Results: In all affected patients, 88.5% were male with a mean age of 42.9 years. The right eye was involved in 64.5% of cases, bilateral in 19% and 73.9% were hyperopic (spherical refraction between 0 and +5.0 diopters).
Of these cases, 51.5% had peri-RPE abnormalities, 17.3% hyperreflective substances at RPE, 19.4% RPE atrophy, 55.3% foveolar atrophy, 3.1% pigment epithelial detachment, 5.2% subretinal fluid persistence, 8.3% fibrin deposits, 68.4% photoreceptor inner and outer segment line interruption and 31.1% external limiting membrane interruption.
Conclusions: Time evolution and number of outbreaks were related to the decrease in foveal and chorodial thickness and in those with worse BCVA and CS. RPE abnormalities and atrophy were related to the age of onset of symptoms. Photoreceptor elongation has been correlated with poor BCVA and inner and outer segment line destructuring and interruption with poor CS.

참고문헌 (Reference)

1 Wirostko WJ, "Topographical choroidal thickness change following pdt for csc: an oct case report" 2012 : 347206-, 2012

2 Song IS, "Time-periodic characteristics in the morphology of idiopathic central serous chorioretinopathy evaluated by volume scan using spectral-domain optical coherence tomography" 154 : 366-375, 2012

3 Maruko I, "Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy" 31 : 1603-1608, 2011

4 Maruko I, "Subfoveal choroidal thickness after treatment of central serous chorioretinopathy" 117 : 1792-1799, 2010

5 Weingessel B, "Predictors of 1-year visual outcome in OCT analysis comparing ranibizumab monotherapy versus combination therapy with PDT in exsudative age-related macular degeneration" 2015

6 Ratanasukon M, "Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy" 7 : 87-92, 2013

7 "Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin:one-year results of 2 randomized clinical trials. TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group" 117 : 1329-1345, 1999

8 Maruko I, "One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy" 31 : 1921-1927, 2011

9 Tsakonas GD, "Multiple spots of photodynamic therapy for the treatment of severe chronic central serous chorioretinopathy" 6 : 1639-1644, 2012

10 김형찬, "Morphologic Changes in Acute Central Serous Chorioretinopathy Using Spectral Domain Optical Coherence Tomography" 대한안과학회 26 (26): 347-354, 2012

11 Fujita K, "Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy" 6 : 1681-1687, 2012

12 Castro-Correia J, "Longterm follow-up of central serous retinopathy in 150 patients" 81 : 379-386, 1992

13 Vasconcelos H, "Long-term chorioretinal changes after photodynamic therapy for chronic central serous chorioretinopathy" 251 : 1697-1705, 2013

14 Matsumoto H, "Fundus autofluorescence of elongated photoreceptor outer segments in central serous chorioretinopathy" 151 : 617-623, 2011

15 Yun Young Kim, "Factors Influencing the Visual Acuity of Chronic Central Serous Chorioretinopathy" 대한안과학회 25 (25): 90-97, 2011

16 Shinojima A, "Detection of morphologic alterations by spectral-domain optical coherence tomography before and af ter half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy" 31 : 1912-1920, 2011

17 Iida T, "Cystoid macular degeneration in chronic central serous chorioretinopathy" 23 : 1-7, 2003

18 Fujita K, "Correlation of integrity of cone outer segment tips line with retinal sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy" 154 : 579-585, 2012

19 Chan WM, "Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level" 87 : 1453-1458, 2003

20 Asensio-Sanchez VM, "Central serous chorioretinopathy as an extradigestive manifestation of Helicobacter pylori gastric infection" 83 : 177-182, 2008

21 Fraunfelder FW, "Cent ral serous chorioretinopathy associated with sildenafil" 28 : 606-609, 2008

22 Jirarattanasopa P, "Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy" 119 : 1666-1678, 2012

23 Gonzalez LS, "Abreu Reyes P. Normal volume and thickness in spectral-domain OCT: literature revision" 23 : 5-, 2012